Crinetics Pharmaceuticals Balance Sheet (2017-2026) | CRNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	178.77M	161.54M	201.19M	145.55M	62.29M	30.91M	32.67M	41.19M	39.55M	142.79M	54.90M	395.92M	302.16M	317.27M	264.55M	94.57M	53.73M	110.90M	101.54M	114.34M
Short-term Investments (Quarter)	24.99M	31.79M	133.01M	174.18M	346.21M	337.45M	301.75M	254.93M	224.98M	411.86M	503.66M	505.04M	560.79M	545.40M	1,089.52M	1,179.56M	0.50M	0.50M	926.35M	1,176.96M
Cash & Current Investments (Quarter)	203.76M	193.32M	334.21M	319.73M	408.51M	368.36M	334.43M	296.12M	264.53M	554.65M	558.55M	900.96M	862.95M	862.67M	1,354.07M	1,274.12M	54.23M	111.40M	1,027.89M	1,291.31M
Receivables - Net (Quarter)																			0.59M	5.68M
Receivables - Other (Quarter)	0.11M	0.09M	0.50M	0.62M	1.16M	0.09M	1.35M	1.27M	0.90M	2.62M	0.09M	3.17M	0.12M	3.37M	8.31M	7.22M	8.38M	6.34M	7.76M	8.96M
Receivables (Quarter)															8.31M				8.35M	14.64M
Work In Process (Quarter)																			2.00M	3.04M
Finished Goods (Quarter)																			0.02M	0.03M
Inventory (Quarter)																			2.02M	3.06M
Prepaid Assets (Quarter)	7.59M	10.65M	0.89M	0.52M	1.63M	1.65M	1.93M	0.58M	20.28M	3.52M	0.45M	3.56M	1.51M	14.92M	20.82M	16.43M	20.40M	4.81M	17.84M	6.43M
Current Assets (Quarter)	211.35M	203.97M	344.72M	328.25M	416.29M	378.32M	345.18M	305.40M	284.81M	575.76M	574.15M	917.23M	874.78M	877.59M	1,375.39M	1,291.06M	1,217.26M	1,121.28M	1,048.34M	1,322.41M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	3.00M	2.90M	2.83M	2.67M	3.15M	3.56M	3.50M	3.27M	3.22M	9.76M	10.88M	11.87M	12.25M	11.71M	12.07M	12.63M	14.67M	14.38M	14.30M	13.50M
Long-Term Deferred Tax (Quarter)															291.54M
Other Non-Current Assets (Quarter)	0.50M	0.50M	0.50M	0.50M	0.50M	1.30M		1.30M	1.30M	1.30M	1.30M	1.30M	1.30M	1.30M	2.83M	1.30M	1.30M	1.30M	22.33M	0.80M
Non-Current Assets (Quarter)	5.57M	5.39M	6.29M	5.04M	5.45M	6.56M	6.99M	8.61M	8.44M	65.78M	61.20M	60.92M	60.76M	59.79M	59.20M	70.27M	72.31M	74.76M	77.92M	78.91M
Assets (Quarter)	216.93M	209.36M	351.01M	333.29M	421.73M	384.88M	352.18M	314.01M	293.25M	641.54M	635.35M	978.15M	935.53M	937.37M	1,434.59M	1,361.33M	1,289.57M	1,196.03M	1,126.26M	1,401.32M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	7.14M	6.15M	8.47M	12.13M	9.04M	13.49M	6.88M	5.89M	20.82M	21.93M	23.20M	28.68M	24.00M	4.94M	21.47M	31.62M	38.09M	33.67M	41.77M	37.49M
Payables (Quarter)	7.14M	6.15M	8.47M	12.13M	9.04M	13.49M	6.88M	5.89M	20.82M	21.93M	23.20M	28.68M	24.00M	4.94M	21.47M	31.62M	38.09M	33.67M	41.77M	37.49M
Accumulated Expenses (Quarter)	3.89M	5.38M	6.59M	4.45M	5.45M	7.72M	9.08M	6.83M	8.60M	12.88M	14.52M	14.83M	20.38M	26.19M	28.89M	16.61M	21.80M	32.40M	35.58M	25.79M
Other Accumulated Expenses (Quarter)	0.89M	0.91M	0.32M	0.96M	1.77M	0.43M	0.34M	0.98M	0.52M	0.99M	3.27M	0.49M	1.08M	0.51M	0.90M	1.67M	1.80M
Current Leases (Quarter)			0.94M			1.02M	1.05M	1.08M	1.11M	3.99M	4.17M	5.79M	7.45M	7.41M	7.15M	6.88M	6.61M	6.44M	6.49M	6.54M
Current Deferred Revenue (Quarter)				2.71M	9.43M	2.32M	8.34M	7.74M	7.15M	6.81M	6.81M	7.20M	6.88M	1.69M	6.88M	6.52M	1.90M	1.64M	1.24M	1.27M
Total Current Liabilities (Quarter)	11.92M	12.44M	15.99M	20.26M	26.11M	24.56M	27.72M	26.32M	32.61M	40.46M	43.94M	51.77M	54.38M	53.56M	59.68M	57.31M	68.40M	74.16M	85.07M	71.09M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)	0.01M	0.01M		7.16M	6.89M	6.65M	6.10M	5.62M	5.07M	5.14M	4.75M	4.74M	4.32M	5.20M	4.70M	4.31M	3.99M	4.11M	3.81M	3.35M
Preferred Stock Liabilities (Quarter)
Non-Current Deferred Tax Liability (Quarter)							0.45M				9.80M				9.75M
Operating Leases (Quarter)	3.56M	3.32M	3.07M	2.82M	2.56M	2.30M	2.02M	1.74M	1.46M	48.18M	47.55M	46.71M	45.87M	45.13M	44.57M	43.94M	43.33M	42.70M	42.05M	41.32M
Other Non-Current Liabilities (Quarter)													0.20M	0.51M	0.83M	1.77M	2.33M	2.89M	3.24M	4.93M
Total Non-Current Liabilities (Quarter)											96.25M		104.57M	103.88M	108.96M	105.56M	115.71M	120.97M	130.93M	115.75M
Total Liabilities (Quarter)	15.49M	15.77M	19.07M	30.24M	35.57M	33.51M	35.85M	33.68M	39.14M	93.79M	96.25M	103.22M	104.77M	104.39M	109.79M	107.33M	118.05M	123.86M	134.17M	120.68M
Shareholder's Equity
Common Equity (Quarter)	201.44M	193.59M	331.94M	303.04M	386.17M	351.37M	316.33M	280.33M	254.12M	547.75M	539.11M	874.93M	830.76M	832.98M	1,324.81M	1,254.00M	1,171.53M	1,072.17M	992.08M	1,280.65M
Liabilities and Shareholders Equity (Quarter)	216.93M	209.36M	351.01M	333.29M	421.73M	384.88M	352.18M	314.01M	293.25M	641.54M	635.35M	978.15M	935.53M	937.37M	1,434.59M	1,361.33M	1,289.57M	1,196.03M	1,126.26M	1,401.32M
Treasury Shares (Quarter)
Retained Earnings (Quarter)	0.01M	-244.46M	-275.25M	-2.19M	-352.30M	-394.18M	-439.17M	-2.51M	-1.71M	-0.86M	0.98M	0.15M	-0.19M	-871.51M	-952.11M	2.00M	1.62M	-1294.61M	-1417.43M	-1545.27M

Research Tools

Developers

Crinetics Pharmaceuticals Balance Sheet (2017-2026) | CRNX

Research Tools

Developers

Crinetics Pharmaceuticals Balance Sheet (2017-2026) | CRNX

Create an account

Sign In

Reset Password